Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

特立氟胺片 - NMPA Drug Approval Details

Approvals/NMPA/Teriflunomide Tablets

Approved

化学药品

Teriflunomide Tablets

盛世泰科生物医药技术（苏州）股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 31, 2021
Approval ID: 8DqbxCzodof
Company: 盛世泰科生物医药技术（苏州）股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8DqbxCzodof
Approval Number: 国药准字H20213974
Generic Name: 特立氟胺片
Generic Name En: Teriflunomide Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 14mg
Reg Date: 2021-12-31
Company Name: 盛世泰科生物医药技术（苏州）股份有限公司
Company Address: 中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期项目C11楼101、102单元
Production Company Name: 南京海纳制药有限公司;江苏盛世药业有限公司
Production Company Address: 南京市江北新区科创大道18号；泰州市医药高新技术产业开发区药城大道六期标准厂房(人才公寓东侧)11幢（固体制剂生产车间片剂生产线）
Company Detail Path: /organization/a3cef02b0b272f6a/sheng-shi-tai-ke-sheng-wu-yi-yao-ji-zhu-su-zhou-gu-fen-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 31, 2021

Approval ID

8DqbxCzodof

Type

化学药品

Back to NMPA Approvals